Just recently, B4GALT5 has been identified as a potential novel target for the diagnosis and therapy in human CRC—increased B4GALT5 mRNA/protein expression and enzymatic activity have been observed in colon tumors, as compared with the normal colon tissue [55]. This evidence concerns the gene B4GALT5 and colonic neoplasm.